America Great Health
Historical Data
View all| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 3, 2026 | $222.05 | $238.38 | $199.00 | $205.30 | 12.61M |
| Jul 2, 2026 | $212.93 | $236.27 | $203.51 | $222.05 | 28.84M |
| Jul 1, 2026 | $219.77 | $229.52 | $208.54 | $212.93 | 11.86M |
| Jun 30, 2026 | $219.39 | $220.17 | $218.02 | $219.77 | 27.37M |
| Jun 29, 2026 | $219.64 | $224.38 | $212.63 | $219.39 | 16.51M |
| Jun 28, 2026 | $219.40 | $221.20 | $218.46 | $219.64 | 20.37M |
| Jun 27, 2026 | $216.22 | $222.91 | $212.91 | $219.40 | 24.94M |
| Jun 26, 2026 | $212.34 | $220.87 | $200.82 | $216.22 | 28.96M |
Company Overview
America Great Health operates in the materials space within the Materials sector. The company generates the majority of its revenue from operating momentum, and has built a durable competitive position through scale, brand, and continued reinvestment. It serves customers globally and is headquartered in the United States. Reported figures on this page are generated for demonstration and are not investment advice.
Leadership
Board 9 · Independent 6 of 9| Date | Firm | Target | Rating |
|---|---|---|---|
| Jun 26 | Goldman Sachs | $317.38 | Hold |
| Jun 1 | KeyBanc | $311.39 | Strong Buy |
| May 31 | Melius Research | $204.30 | Neutral |
| May 18 | Mizuho | $345.52 | Strong Buy |
| May 13 | Needham | $368.29 | Buy |
| May 11 | JPMorgan | $346.28 | Buy |
Politician Trades
View allWhat's Happening Right Now
- Apr 21, 2025 · Audit Concern ↗ — A 2025 report highlighted that some annual reports, potentially including AAGH's, have been filed without an auditor's consent or opinion, raising red flags about financial disclosure integrity.
- Dec 3, 2022 · Market Data ↗ — TradingView listed price and chart data for BIOE (OTC), a separate ticker referenced alongside AAGH coverage.
- Jan 8, 2022 · Market Data ↗ — TradingView listed price and chart data for PLSH (OTC), another unrelated OTC ticker appearing in the same news feed.
- Mar 27, 2021 · Financials Page ↗ — TradingView hosted a financial statements page for AAGH (OTC), though no substantive figures were reported.
- Jul 24, 2017 · Market Data ↗ — An earlier TradingView listing tracked AAGH's OTC stock price and chart back in 2017.
Snapshot
America Great Health (AAGH) has no Form 10-K on file, meaning there are no audited revenue, profit, or balance-sheet figures available for review. Without a filed annual report, standard financial metrics such as sales, earnings, assets, or liabilities cannot be verified or disclosed. The available news flow consists mainly of third-party stock-tracking listings rather than substantive corporate or financial updates. Notably, a 2025 report specifically flagged concerns about annual reports—potentially including AAGH's—being filed without auditor consent or opinion, underscoring a lack of verified financial transparency.
Bottom Line
AAGH currently offers no audited financial data, making it impossible to assess revenue, profitability, or balance-sheet health through standard means. Combined with reports of annual filings lacking auditor consent, this represents a significant transparency and reliability risk for investors. Any interest in AAGH would be purely speculative until verified, audited financials become available.